Fund HoldingsFrazier Life Sciences Management, L.P.

Total Portfolio Value
$2.41B
Total Bought
$290.13M
Total Sold
$305.14M
Net Transaction
-$15.01M
Filing Period:
Securities
SharesValue ($K)
Q3 2024
Q4 2024
Change
Q3 2024
Q4 2024
Weight (%)
Change
NEWAMSTERDAM PHARMA COMPANY
ORDINARY SHARES
12,855,19415,916,418+3,061,224213,396409,05216.98%+195,656
VERONA PHARMA PLC3,383,9503,383,950097,356157,1516.52%+59,794
ARCUTIS BIOTHERAPEUTICS INC(ARQT)8,785,2848,785,284081,703122,3795.08%+40,676
TARSUS PHARMACEUTICALS INC(TARS)1,587,5271,587,527052,21487,9013.65%+35,688
DISC MEDICINE INC(IRON)1,754,8341,754,834086,233111,2564.62%+25,024
TREVI THERAPEUTICS INC(TRVI)7,381,09010,664,774+3,283,68424,65343,9391.82%+19,286
MIRUM PHARMACEUTICALS INC(MIRM)6,570,3926,570,3920256,245271,68611.28%+15,440
PLIANT THERAPEUTICS INC01,120,803+1,120,803014,7610.61%+14,761
BRIDGEBIO PHARMA INC(BBIO)3,760,4573,800,457+40,00095,741104,2854.33%+8,543
PALVELLA THERAPEUTICS INC NE(PVLA)0653,892+653,89207,8470.33%+7,847
NEWAMSTERDAM PHARMA COMPANY
*W EXP 99/99/999
0500,333+500,33307,1300.30%+7,130
ELEDON PHARMACEUTICALS INC01,176,735+1,176,73504,8480.20%+4,848
HILLEVAX INC10,617,06210,617,062018,68621,9770.91%+3,291
DESIGN THERAPEUTICS INC1,892,5471,953,547+61,00010,18212,0530.50%+1,871
ACADIA PHARMACEUTICALS INC470,338470,33807,2348,6310.36%+1,397
ALKERMES PLC(ALKS)576,129601,129+25,00016,12617,2880.72%+1,163
89BIO INC1,000,0001,000,00007,4007,8200.32%+420
MACROGENICS INC3,010,7273,175,665+164,9389,90510,3210.43%+416
IMMUNOCORE HLDGS PLC(IMCR)108,762108,76203,3863,2080.13%-177
IMMATICS N.V(IMTX)1,354,7112,147,911+793,20015,45715,2720.63%-186
ELEVATION ONCOLOGY INC5,993,5795,993,57903,5963,3720.14%-224
PIERIS PHARMACEUTICALS INC15,9420-15,9422670-267
ACLARIS THERAPEUTICS INC264,3770-264,3773040-304
ORUKA THERAPEUTICS INC(ORKA)477,327583,327+106,00011,69911,3110.47%-389
DAY ONE BIOPHARMACEUTICALS I
COM
689,655689,65509,6078,7380.36%-869
KALVISTA PHARMACEUTICALS INC3,687,8674,887,867+1,200,00042,70641,4001.72%-1,305
ASCENDIS PHARMA A/S(ASND)133,333133,333019,90818,3560.76%-1,552
ARVINAS INC285,331285,33107,0285,4700.23%-1,558
REVOLUTION MEDICINES INC(RVMD)997,455997,455045,23543,6291.81%-1,606
ALLOGENE THERAPEUTICS INC2,867,7502,867,75008,0306,1080.25%-1,921
ADVERUM BIOTECHNOLOGIES INC1,069,2441,069,24407,5064,9930.21%-2,513
NUVATION BIO INC(NUVB)1,218,2360-1,218,2362,7900-2,790
COGENT BIOSCIENCES INC(COGT)936,576936,576010,1157,3050.30%-2,810
MERUS N V373,100373,100018,64015,6890.65%-2,951
MEREO BIOPHARMA GROUP PLC5,097,7795,097,779020,95217,8420.74%-3,110
NEWAMSTERDAM PHARMA COMPANY
*W EXP 99/99/999
500,3330-500,3333,5020-3,502
ERASCA INC(ERAS)19,391,68719,391,687052,93948,6732.02%-4,266
LEXEO THERAPEUTICS INC1,250,786955,515-295,27111,3076,2870.26%-5,020
AUTOLUS THERAPEUTICS PLC4,623,3244,623,324016,78310,8650.45%-5,918
PEPGEN INC702,6940-702,6946,0080-6,008
CG ONCOLOGY INC(CGON)770,000770,000029,05222,0840.92%-6,968
ULTRAGENYX PHARMACEUTICAL IN(RARE)633,715658,715+25,00035,20327,7121.15%-7,491
PUMA BIOTECHNOLOGY INC3,062,5580-3,062,5587,8100-7,810
SAVARA INC(SVRA)8,157,3858,660,379+502,99434,58726,5871.10%-8,000
ROCKET PHARMACEUTICALS INC1,485,6301,479,025-6,60527,44018,5910.77%-8,848
ORIC PHARMACEUTICALS INC(ORIC)4,142,8553,888,238-254,61742,46431,3781.30%-11,086
AGIOS PHARMACEUTICALS INC(AGIO)1,044,1541,069,754+25,60046,39235,1521.46%-11,240
SOLENO THERAPEUTICS INC875,667699,159-176,50844,21231,4271.30%-12,785
SILENCE THERAPEUTICS PLC1,148,5911,148,591020,8817,9020.33%-12,979
TYRA BIOSCIENCES INC(TYRA)731,0200-731,02017,1860-17,186
RHYTHM PHARMACEUTICALS INC(RYTM)2,416,9521,869,808-547,144126,624104,6724.34%-21,952
EDGEWISE THERAPEUTICS INC(EWTX)2,832,8671,271,245-1,561,62275,60933,9421.41%-41,667
MBX BIOSCIENCES INC(MBX)5,985,3475,985,3470155,499110,3104.58%-45,189
ANAPTYSBIO INC2,209,1891,573,719-635,47074,00820,8360.86%-53,172
VAXCYTE INC(PCVX)879,405539,405-340,000100,49044,1561.83%-56,334
KRYSTAL BIOTECH INC(KRYS)988,460788,460-200,000179,929123,5205.13%-56,409
PHATHOM PHARMACEUTICALS INC(PHAT)10,109,27910,109,2790182,77682,0873.41%-100,688
Page 1 of 1